Day2, July 6: Morning-Panel
Elke Glasmacher is since November 2021 heading the Chapter of Biomarker Discovery in Roche Diagnostics solutions, responsible for the implementation of a new strategy, new governance structures as well as acquisition of collaborations in the Open and Innovation space. From 2017-2021 she had successfully led and buildup a department for Immune and Cell Biology in Roche Pharma (pRED) in a transformation and initiated various changes, implementing the way for more innovation, modern ways of working and diverse and inclusive environment.
In her education, she worked at Grünenthal in Aachen, studied in Cologne Biology and moved for her main courses in Biochemistry to Boston and then the Max Planck of Biochemistry. She then switched to immunology for her PhD thesis and described a mechanism that prevents autoreactive T cells in lupus. She moved in 2010 to Genentech as a Postdoctoral Fellow and discovered a genomic
regulatory element that drives differentiation programs of immune cells. In 2013 she established an independent investigator laboratory at the Helmholtz Center Munich where she continued to work on molecular factors driving immune cell fate and activation.
Copyright © 2022 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten